Pharmaceutical companies are facing new demands from consumers, regulators, insurers and independent groups. Constructive engagement with patients and consumers can form a crucial link between these stakeholders, providing better outcomes and value for pharmaceutical companies
To understand how the pharmaceutical industry can position itself to better benefit from patient engagement, PwC’s Health Research Institute (HRI) analyzed recent regulatory changes and surveyed consumers about their willingness to engage with pharmaceutical companies and other healthcare entities. Key findings include:
PwC’s Pharmaceutical and life sciences works with you from strategy through execution. Discover other ways we’ll help you succeed in the New Health Economy.
Principal, PwC Health Advisory Services
Tel: +1 (617) 283 2638